Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review

Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review

BackgroundSorafenib was the first drug approved for advanced hepatocellular carcinoma (HCC). However, it is limited by poor efficacy for HCC with portal vein tumor thrombus (PVTT). Some studies suggested that hepatic artery infusion chemotherapy (HAIC) could provide survival benefits to patients wit...

Full description

Bibliographic Details
Main Authors:	Wei Zhang, Deliang Ouyang, Zhangkan Huang, Xu Che
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Oncology
Subjects:	hepatocellular carcinoma portal vein tumor thrombosis sorafenib hepatic arterial infusion chemotherapy prognosis meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1085166/full

Similar Items

Hepatic Arterial Infusion Chemotherapy Followed by Lipiodol Infusion for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Single-Center Experience
by: Kuan-Ting Chen, et al.
Published: (2021-07-01)

INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus
by: Xiaodong Song, et al.
Published: (2020-08-01)

TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study
by: Biao Yang, et al.
Published: (2021-12-01)

Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study
by: Yanyan Cao, et al.
Published: (2021-08-01)

Chemoembolization Plus Radiotherapy versus Chemoembolization Plus Sorafenib for the Treatment of Hepatocellular Carcinoma Invading the Portal Vein: A Propensity Score Matching Analysis
by: Hee Ho Chu, et al.
Published: (2020-04-01)

A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
by: Hyun Yang, et al.
Published: (2017-06-01)

Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score‐matched survival analysis
by: Yang Gao, et al.
Published: (2019-11-01)

A combination of portal vein stent insertion and endovascular iodine-125 seed-strip implantation, followed by transcatheter arterial chemoembolization with sorafenib for treatment of hepatocellular carcinoma-associated portal vein tumor thrombus
by: Shuangxi Li, et al.
Published: (2021-12-01)

Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
by: Jina Kim, et al.
Published: (2023-06-01)

Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma
by: Michele Basso, et al.
Published: (2010-11-01)

Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
by: Mohamed Houseni, et al.
Published: (2023-08-01)

Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
by: Jina Kim, et al.
Published: (2022-05-01)

New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
by: Hyun Young Woo, et al.
Published: (2015-06-01)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
by: Su Jong Yu, et al.
Published: (2023-03-01)

Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus
by: Zili Hu, et al.
Published: (2023-09-01)

Efficacy of radiotherapy in combined treatment of hepatocellular carcinoma patients with portal vein tumor thrombus: a real-world study
by: Ying Xiao, et al.
Published: (2024-02-01)

Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas
by: Xiao-Hui Zhao, et al.
Published: (2022-10-01)

HEPATOSPLENIC SCHISTOSOMIASIS-ASSOCIATED CHRONIC PORTAL VEIN THROMBOSIS: RISK FACTOR FOR HEPATOCELLULAR CARCINOMA?
by: George Felipe Bezerra Darce, et al.
Published: (2023-09-01)

Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
by: Kazuomi Ueshima, et al.
Published: (2020-07-01)

New Regimen of Combining Hepatic Arterial Infusion Chemotherapy and Lipiodol Embolization in Treating Hepatocellular Carcinoma with Main Portal Vein Invasion
by: Ming-Feng Li, et al.
Published: (2022-12-01)

Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma
by: Hideki Iwamoto, et al.
Published: (2021-02-01)

Cost-Effectiveness Analysis of Hepatic Arterial Infusion of FOLFOX Combined Sorafenib for Advanced Hepatocellular Carcinoma With Portal Vein Invasion
by: Meiyue Li, et al.
Published: (2021-03-01)

Short-term and long-term outcomes of liver resection for HCC patients with portal vein tumor thrombus
by: Lei Huo, et al.
Published: (2019-03-01)

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
by: Moon Haeng Hur, et al.
Published: (2023-07-01)

Portal vein tumor thrombus from gastric cancer
by: Sidney Ching Liang Ong, et al.
Published: (2018-12-01)

Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma
by: Duo Hong, et al.
Published: (2021-09-01)

Comparative efficacy and safety of multimodality treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: patient-level network meta-analysis
by: John Hang Leung, et al.
Published: (2024-02-01)

Usefulness of Imaging and Biological Tools for the Characterization of Portal Vein Thrombosis in Hepatocellular Carcinoma
by: Călin Burciu, et al.
Published: (2022-05-01)

Folate levels in hepatocellular carcinoma patients with portal vein thrombosis
by: Giulia Malaguarnera, et al.
Published: (2020-11-01)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
by: Do Young Kim
Published: (2017-06-01)

Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Thrombosis: A Perspective on Survival
by: Yadav Ajit, et al.
Published: (2014-11-01)

Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
by: Kim Ji-Yoon, et al.
Published: (2013-01-01)

Safety and efficacy of low-dose transarterial chemoembolization in the hepatocellular carcinoma patients with portal vein tumor thrombosis
by: Won-Gyom Choe, et al.
Published: (2018-01-01)

Suppurative Thrombosis of the Portal Vein (Pylephlebits): A Systematic Review of Literature
by: Dorde Jevtic, et al.
Published: (2022-08-01)

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma
by: Fei-Xiang Wu, et al.
Published: (2017-09-01)

Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience
by: Yashwant Patidar, et al.
Published: (2021-04-01)

DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
by: Junwei Chen, et al.
Published: (2022-11-01)

Extrahepatic portal vein obstruction and portal vein thrombosis in special situations: Need for a new classification
by: Zeeshan A Wani, et al.
Published: (2015-01-01)

Case Report: Successful conversion and salvage resection of huge hepatocellular carcinoma with portal vein tumor thrombosis and intrahepatic metastasis via sequential hepatic arterial infusion chemotherapy, lenvatinib plus PD-1 antibody followed by simultaneous transcatheter arterial chemoembolization, and portal vein embolization
by: Xin Luo, et al.
Published: (2023-10-01)

Complete cure of advanced hepatocellular carcinoma with right adrenal gland metastasis and portal vein thrombosis by multiple applications of an interdisciplinary therapy: Case report with 8-year follow up
by: Hojung Jung, et al.
Published: (2018-12-01)